Abstract
Corticosteroids are commonly employed within oncology primarily as either part of a direct treatment regimen or more broadly a supportive care modality. However, despite the widespread and well-established benefits of corticosteroids in these roles, a myriad of side effects can develop in correlation with the chronicity and/or dosage required in use. In particular, neurological side effects can be pronounced, leading to a limitation in their cumulative use and a concern for the potential significant impact on patient quality of life. Neurologic complications also arise during the care of patients with cancer as a direct consequence of additional supportive care medications, including antiepileptics, analgesics, antiemetics, and antidepressants in particular, or during the management of tumor-associated CNS vascular damage, including ischemic infarction or hemorrhagic injury. Here, we review the spectrum of corticosteroid-induced neurologic complications as well as the neurologic complications that arise secondary to supportive care measures of patients within oncology.
Original language | English (US) |
---|---|
Title of host publication | Neurological Complications of Systemic Cancer and Antineoplastic Therapy |
Publisher | Elsevier |
Pages | 553-561 |
Number of pages | 9 |
ISBN (Electronic) | 9780128219768 |
ISBN (Print) | 9780128219775 |
DOIs | |
State | Published - Jan 1 2022 |
Keywords
- Corticosteroids
- Depression
- Insomnia
- Myopathy
- Neuropsychiatric
- Oncology
- Opioids
- Pain
- Patients
- Seizures
- Steroid
ASJC Scopus subject areas
- General Medicine